Samsara BioCapital »

AgomAb Therapeutics NV shares owned by Samsara BioCapital

Quarter-by-quarter ownership of AgomAb Therapeutics NV shares owned by Samsara BioCapital from 13F filings

Historical chart of Samsara BioCapital investment in AgomAb Therapeutics NV

Tip: Access up to 7 years of quarterly data

All positions including AgomAb Therapeutics NV held by Samsara BioCapital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AgomAb Therapeutics NV by Samsara BioCapital

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.3M 600k 10.49

More positions owned by Samsara BioCapital

Scholar Rock Hldg Corp (SRRK)
Mineralys Therapeutics (MLYS)
Alumis (ALMS)
Septerna (SEPN)
Kalaris Therapeutics (KLRS)
Spyglass Pharma Com Shs
Neurogene (NGNE)
Inventiva Sa Ads (IVA)
Sutro Biopharma Com Shs (STRO)
Jade Biosciences Com New (JBIO)
Vtv Therapeutics Cl A New (VTVT)
Aquestive Therapeutics (AQST)
X4 Pharmaceuticals Com New (XFOR)
Nkarta (NKTX)
Arcellx Common Stock (ACLX)

View all positions for Samsara BioCapital

Top funds holding AgomAb Therapeutics NV

Sanofi
Cormorant Asset Management
TCG Crossover Management
Federated Investors
Casdin Capital
Andera Partners
Nantahala Capital Management
Standard Life Aberdeen
Samsara BioCapital
Perceptive Advisors
LMR Partners
Seven Grand Managers
Redmile Group
Millennium Management
Alyeska Investment Group

View all funds holding AgomAb Therapeutics NV